Skip to content
Storytelling Co – Lifestyle
Author:
Kos Biotechnology Partners
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
September 10, 2026
Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million
June 13, 2026